Axcelead Drug Discovery Partners (DDP)
Is this your company? Claim this profile
Analytical & Bioanalytical Services
Contract Research Organization
Company Overview
About
Axcelead Drug Discovery Partners (DDP) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:Japan
Founded:2003
Employees:2,443
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
Europe
Regulatory Approvals
Drug Approval TPWGUO
PMDA · #APR-VMZMUC7T · 2022-10-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-F5K4SVZF
Issued: 2020-01-28
Expires: 2025-02-21
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-J7KPACQP
Issued: 2020-07-05
Expires: 2025-04-24
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-ON851SLR
Issued: 2020-07-21
Expires: 2025-10-07
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-0OA0ZDFH
Issued: 2020-06-03
Expires: 2025-03-01
Loading CDMO intelligence...
Key facts about Axcelead Drug Discovery Partners (DDP)
- Axcelead Drug Discovery Partners (DDP) is headquartered in Japan.
- Axcelead Drug Discovery Partners (DDP) was founded in 2003.
- Axcelead Drug Discovery Partners (DDP) has 2,443 employees.
- Axcelead Drug Discovery Partners (DDP)'s capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.
Find CDMOs like Axcelead Drug Discovery Partners (DDP)
Directory pages this company appears in, each with the full list of matching manufacturers.